ClinicalTrials.Veeva

Menu

The Association of G9a Protein and the Outcome of Patients With Cervical Cancer

F

Far Eastern Memorial Hospital

Status

Completed

Conditions

Cervical Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01505751
100078-E

Details and patient eligibility

About

G9a protein was approved to be highly associated with recurrence of breast cancer, gastric cancer, hepatocellular cancer, prostate cancer and lung cancer. Therefore, the aim of this study was to clarify the association and G9a protein and cervical cancer by analyzing the immunohistochemical staining of G9a protein to the histopathologic specimen of cervical cancer and clinical data.

Enrollment

69 patients

Sex

Female

Ages

20 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • cases with cervical cancer

Trial design

69 participants in 1 patient group

cervical cancer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems